Giant Mesenteric Cyst: A Case Series.

Int Med Case Rep JSep 24, 2026 (epub)
Case ReportPediatricsGeneral SurgeryPathology (Anatomic & Clinical)Open access

Omar Adam Sheikh, Shukri Said Mohamed, Ahmet Sarac et al.

✦ AI-curated · Sources linked

Case in brief

This report details two pediatric cases of mesenteric cysts. A 10-month-old male presented with abdominal distension and intermittent non-bilious vomiting, while a 5-year-old boy exhibited severe abdominal distension due to a large intra-abdominal mass. Both were diagnosed with mesenteric cysts after clinical evaluation and imaging, and underwent successful surgical excision, with no postoperative complications or recurrence noted.

Diagnostic / clinical pearl

Mesenteric cysts, though rare, should be considered in the differential diagnosis of abdominal masses in children, especially when presenting with nonspecific symptoms like distension and vomiting.

Source

PubMed · PMID 42812785Free full text on PubMed Central

Published in Int Med Case Rep J. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.